Edinburgh BioQuarter

Edinburgh BioQuarter is an initiative in the development of Scotland's life sciences industry, which, as of August 2020[update], employs more than 39,000 people in over 750 organisations.

BioQuarter has generated an estimated £2.72 billion in gross value added[3] from its research, clinical and commercial activities, and a further £320 million from its development.

[7] The first commercial facility on BioQuarter, the NINE – Life Sciences Innovation Centre, was established in 2012 to house burgeoning spinouts and startup life sciences companies;[8] this was joined in 2016 by commercial modular facilities in the form of BioCube 1 and BioCube 2.

[10] The pipeline of academic and clinical developments includes the Usher Institute[11] (due to open in 2024), the co-location of Biomedical and Medical Teaching and NHS Lothian’s Princess Alexandra Eye Pavilion.

In 2022, a multi-million-pound research programme to develop treatments for lung infections such as COVID-19 and future pandemics was announced.